Effects of a fast disintegrating/ rapid release oral formulation of sumatriptan on functional ability in patients with migraine

References

• Osterhaus JT, Townsend RJ, Gandek B, et al. Measuring the functional status and well-being of patients with migraine headache. Headache 1994;34:337–43
   PubMed Web of Science ®Google Scholar
• Dahlof C. Assessment of health-related quality of life in migraine. Cephalalgia 1993;13:233–7
   PubMed Web of Science ®Google Scholar
• Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache 1993;33:29–35
   PubMed Web of Science ®Google Scholar
• Pryse-Phillips W, Findlay H, Tugwell P, et al. A Canadian population survey on the clinical, epidemiologic, and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992;19:333–9
   Google Scholar
• Edmeads J, Mackell JA. The economic impact of migraine: an analysis of direct and indirect costs. Headache 2002;42:501–9
   PubMed Web of Science ®Google Scholar
• Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999; 159:813–8
   PubMed Web of Science ®Google Scholar
• Stang P, Cady R, Batenhorst A, et al. Workplace productivity: a review of the impact of migraine and its treatment. Pharmacoeconomics 2001;19:231–44
   PubMed Web of Science ®Google Scholar
• Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource use and lost labor costs of migraine headache in the United States. Pharmacoeconomics 1992;2:67–76
   Google Scholar
• Matchar DB, Young WB, Rosenberg JH, et al. Multispecialty consensus on diagnosis and treatment of headache: pharmacological management of acute attacks. Neurology 2000;54 [www.aan.com/public/practiceguidelines/03.pdf. Accessed 16 February 2002]
   Google Scholar
• Kaniecki RG. Mixing sumatriptan: a prospective study of stratified care using multiple formulations. Headache 2001;41:862–6
   PubMed Web of Science ®Google Scholar
• Gruffydd-Jones K, Hood CA, Price DB. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice. Cephalalgia 1998;17:31–6
   Google Scholar
• Dahlöf CG, Saiers JA. Sumatriptan injection and tablets in clinical practice: results of a survey of 707 migraineurs. Headache 1998;38: 756–63
   Google Scholar
• Sramek JJ, Hussey EK, Clements B, et al. Oral sumatriptan pharmacokinetics in the migraine state. Clin Drug Invest 1999;17:137–44
   Web of Science ®Google Scholar
• Volans GN. Migraine and drug absorption. Clin Pharmacokinet 1978; 3:313–8
   PubMed Web of Science ®Google Scholar
• Walls C, Sidhu J, Lewis A, et al. Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers. Curr Med Res Opin [in press]
   Google Scholar
• Cady RK, Sheftell F, Lipton RB, et al. Effects of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000;22:1035–48
   PubMed Web of Science ®Google Scholar
• Cady RK, Lipton RB, Hall C, et al. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 2000;40:792–7
   PubMed Web of Science ®Google Scholar
• Winner P, Mannix LK, Putnam DG, et al. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 2003;78:1214–22
   PubMed Web of Science ®Google Scholar
• Carpay J, Schoenen J, Ahmad F, et al. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin Ther 2004;26:214–23
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. Classification of headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1–96
   Google Scholar
• Schulman EA, Cady RK, Henry D, et al. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2000;75:782–9
   PubMed Web of Science ®Google Scholar
• Cady RC, Ryan R, Jhingran P, et al. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 1998;158:1013–8
   PubMed Web of Science ®Google Scholar
• Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997;39:320–7
   Google Scholar
• Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002;42(Suppl 1):3–9
   Google Scholar
• Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000;20:554–60
   Google Scholar
• Bouchard J, Cortelli P, Dahlöf C, et al. A multinational investigation of the impact of subcutaneous sumatriptan. IV: patient satisfaction. Pharmacoeconomics 1997;11(Suppl 1): 43–50
   Google Scholar
• MacGregor EA, Brandes J, Eikerman A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003;43:19–26
   Google Scholar
• Lipton RB, Stewart WF. Acute migraine therapy: do doctors know what migraine patients want from therapy? Headache 1999;39(Suppl 2):S20–S26
   Google Scholar
• Walls C, Sidhu J, Lewis A, et al. Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers. Curr Med Res Opin 2004;20:803–9
   PubMed Web of Science ®Google Scholar
• Halpern MT, Lipton RB, Cady RK, et al. Costs and outcomes of early versus delayed migraine treatment with sumatriptan. Headache 2002;42:984–99
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646–57
   PubMed Web of Science ®Google Scholar